Prakash Shantilal
About Prakash Shantilal
Data last updated:
Prakash Shantilal is a Director at Mediscribe (India) Private Limited (since 1999) and Director at Atria Clinical Research India Private Limited (since 2017). The companies operate in Business Outsourcing and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹5.91 Cr; the largest is Mediscribe (India) Private Limited at ₹5.90 Cr (FY 2025). Earlier, Prakash Shantilal was a Director at Stenmed Health Services India Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
_PRIVATE_LIMITED.webp){kind=small} Mediscribe (India) Private Limited U72300KA1999PTC024942 | Director | 22 Mar 1999 | 1999 | ₹5.90 Cr (FY 2025) | Active |
 Atria Clinical Research India Private Limited U73100KA2017PTC106019 | Director | 31 Aug 2017 | 2017 | ₹84,100 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Stenmed Health Services India Private Limited U85100KA2009PTC051625 | Director | 25 Nov 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Prakash Shantilal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavitha Prakash | 03123743 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Pradeep Shanthilal | 00735726 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Rajani Bharat Tukol | 03123750 | Mediscribe (India) Private Limited | Director |
| Sudhirkumar Ambalal Patel | 08973646 | Atria Clinical Research India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prakash Shantilal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prakash Shantilal
Prakash Shantilal currently holds 2 directorships: Mediscribe (India) Private Limited (Director, since 22 Mar 1999, revenue ₹5.90 Cr (FY 2025)); Atria Clinical Research India Private Limited (Director, since 31 Aug 2017, revenue ₹84,100 (FY 2024)).
Prakash Shantilal was first appointed on 22 Mar 1999 as Director at Mediscribe (India) Private Limited. The most recent appointment on record is 31 Aug 2017 at Atria Clinical Research India Private Limited.
The 2 current companies of Prakash Shantilal that report revenue have a combined latest revenue of ₹5.91 Cr: Mediscribe (India) Private Limited ₹5.90 Cr (FY 2025); Atria Clinical Research India Private Limited ₹84,100 (FY 2024).
Prakash Shantilal held 1 earlier board appointment: Stenmed Health Services India Private Limited (Director, from 25 Nov 2009).
The current boards of Prakash Shantilal's companies include Kavitha Prakash (Mediscribe (India) Private Limited), Pradeep Shanthilal (Mediscribe (India) Private Limited), Rajani Bharat Tukol (Mediscribe (India) Private Limited), Sudhirkumar Ambalal Patel (Atria Clinical Research India Private Limited).